Eloxx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 401-425 of 917 matching filings.

Per page
25
Current page
17
S-8 File 333-222499

S-8

Filing date
10 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-56243

SC 13D

Filing date
02 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Dec 2017
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-56243

SC 13D

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SCHEDULE 13G

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SC 13G

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SC 13G

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-56243

SC 13D

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SC 13G

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
28 Dec 2017
Reporting date
26 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Dec 2017
Reporting date
26 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-56243

SC 13D/A

Filing date
27 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
27 Dec 2017
Reporting date
26 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-56243

SC 13D/A

Filing date
27 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .